Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.（VNDA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
vnda · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 19 位华尔街分析师
Buy
19 位分析师
共识
评级分布
12 个月目标价
High
$21.00
Consensus
$14.25
+139.8% upside
Low
$7.50
Median: $14.25 · Last Close: $5.94
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$14.25
139.8% upside
High Target
$21
253.4%
Low Target
$7.5
26.2%
Current Price
$5.94
as of today
Based on analyst price targets, the VNDA stock price prediction for the next 12 months ranges from $7.5 to $21. The consensus VNDA price forecast of $14.25 implies 139.8% upside from the current price of $5.94.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.81 | ↓ 2.21% |
1-day model range: $5.76–$5.86. Peak: $5.86 (-2.21%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VNDA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-31 | Jefferies | Maintains | Hold→Hold |
| 2025-12-31 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-30 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Vanda Pharmaceuticals Inc. (VNDA) stock. Of the recent 65 rating actions, 6 were upgrades and 8 were downgrades. 19 analysts currently cover VNDA.
分析师推荐趋势
VNDA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$263M
↓ 38.2% YoY
Revenue Next Year
$356M
↑ 35.6% YoY
EPS This Year
$-2.30
EPS Next Year
$-0.87
↓ 62.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast VNDA EPS of $-2.30 for the current fiscal year, based on estimates from 4 analysts. The VNDA revenue forecast is $263M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
VNDA 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。VNDA 的共识目标价为 $14.25（+139.8% 上行空间），分析师共识为 Buy。
VNDA 的短期预测（明日）为 $5.81（-2.21%）。
Vanda Pharmaceuticals Inc. 在 NASDAQ 上市，代码 VNDA。VNDA 在 2027 年的整体展望偏积极，在覆盖分析师中约 68% 对应 Buy 共识。
常见问题
VNDA 预测 · 8 个问题根据 19 位华尔街分析师，VNDA 的 12 个月平均目标价为 $14.25，最高 $21.00、最低 $7.50。若有图表，中位目标价可在上方查看。相对当前价 $5.94，隐含约 +139.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.